Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Urticaria Clinical Trials
Urticaria clinical trials are recruiting across 58 cities. Here are the cities with the most active studies:
Urticaria Trial Phases
14 research organizations are sponsoring urticaria trials.
About Urticaria
Urticaria (hives) presents as raised, itchy welts on the skin triggered by allergens, medications, infections, or other factors. Acute urticaria resolves within six weeks, while chronic forms persist longer. Treatment includes antihistamines, corticosteroids for severe episodes, and biologics for chronic cases.
Clinical trials are advancing new treatments for urticaria. Currently, 21 studies are recruiting a combined 6,505 participants across the United States. Research is being conducted by 14 organizations including Novartis Pharmaceuticals, Sanofi, Celldex Therapeutics and 11 others.
2026 Urticaria Research Landscape
As of July 2026, the urticaria clinical trial landscape includes 21 actively recruiting studies across 58 cities in the United States. These studies are collectively seeking 6,505 participants, with an average enrollment target of 310 per study.
The research spans multiple phases of development: 9 studies are in PHASE3, 5 studies are in PHASE2, 2 studies are in PHASE1, 1 study is in PHASE4. The presence of Phase 3 trials indicates that some urticaria treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 14 different organizations, including Novartis Pharmaceuticals, Sanofi, Celldex Therapeutics, CSL Behring, Pfizer, and 9 others. The large number of sponsors reflects significant research interest and investment in urticaria treatment advancement.
Geographically, urticaria trials are most concentrated in Little Rock, Arkansas (6 trials); St Louis, Missouri (6 trials); San Diego, California (6 trials); Birmingham, Alabama (4 trials); Miami, Florida (4 trials) and 7 other cities.
Featured Urticaria Studies
Highlighted recruiting studies for urticaria, selected by enrollment size and research scope.
Remibrutinib in Real-world Clinical Practice
Prospective, multi-country, non-interventional study in patients with CSU where the treatment decision prior enrolment has been made to either escalate current sgH1-AHs treatment or escalate/switch current treatment to remibrutinib. The primary aim of this study is to gather real-world effectiveness and safety data for remibrutinib, a new treatment option, covering a broader, real-world clinical p...
Remibrutinib in Real-world Clinical Practice - a US Sub-study
Prospective, non-interventional study in patients with CSU where the treatment decision prior enrolment has been made to either escalate current sgH1-AHs treatment or escalate/switch current treatment to remibrutinib. The primary aim of this study is to gather real-world effectiveness and safety data for remibrutinib, a new treatment option, covering a broader, real-world clinical practice populat...
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
This is a US, multi-center, randomized, double-blind, double-dummy, Phase 3b study to evaluate efficacy of remibrutinib (25 mg twice daily \[b.i.d.\] by mouth \[p.o.\]) compared to dupilumab (600 mg loading dose administered subcutaneously (s.c.) followed by 300 mg every 2 weeks s.c.) at early timepoints (4 weeks and earlier), when administered as an add-on treatment to second generation H1-antihi...
Frequently Asked Questions About Urticaria Clinical Trials
Are there urticaria clinical trials near me?
Yes, there are 21 urticaria clinical trials currently recruiting across 58+ cities in the United States, including Little Rock, Arkansas; St Louis, Missouri; San Diego, California. Browse the studies above to find one at a location convenient for you.
How do I join a urticaria clinical trial?
To join a urticaria clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are urticaria clinical trials free?
Yes, participation in urticaria clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of urticaria treatments are being studied?
Current urticaria clinical trials are testing a range of approaches across PHASE3 (9 studies), PHASE2 (5 studies), PHASE1 (2 studies), PHASE4 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 14 research organizations.
Is it safe to participate in urticaria clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 18, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 18, 2026 · Data from ClinicalTrials.gov